Semiconductor technology company BlueGlass (ASX: BLG) has opened its new $6 million manufacturing laboratory in Sydney as it moves to commercialise novel opto-electronics devices.
The company is developing its patented remote plasma chemical vapour deposition (RPCVD) technology to make high performance and cheaper devices.
The new laboratories incorporate two new clean rooms which house two semiconductor deposition systems, significantly expending the company’s manufacturing capacity.
BlueGlass CEO Giles Bourne said: “These new systems and infrastructure allow us to expand our revenue-generating epitaxy foundry services (and) accelerate our RPCVD development.”
Bourne said negotiations with three industry partners undertaking product development trials could now be accelerated.
The trials are being undertaken in the field of LED lights for power electronics by semiconductor equipment manufacturer Veeco Instruments, Chinese chip manufacturer HC SemiTek and lighting manufacturer Lumileds.
BlueGlass, 20 per cent owned by a subsidiary of Japan’s Sumitomo, is developing technology which originated in research at Macquarie University.
The technology has potential in lighting technology, light emitting diodes (LEDs), power electronics and concentrated solar cells
Picture: BlueGlass/semiconductor wafer testing
Subscribe to our free @AuManufacturing newsletter here.